Anaphylaxis in Children: Tryptase Ratio for Better Diagnosis
- A new diagnostic approach may improve the accuracy of anaphylaxis diagnosis in children.
- the research, led by Moïse Michel, PhD, at Nîmes University Hospital in France, involved reviewing the medical records of 315 children admitted to the emergency department between 2011...
- The diagnosis of anaphylaxis was confirmed in 175 children who exhibited at least one extracutaneous systemic symptom along with evidence of systemic mast cell activation or allergic sensitization...
A groundbreaking study reveals a new tryptase ratio to considerably improve anaphylaxis diagnosis in children. learn how this innovative approach, using a specific ratio of serum acute tryptase to baseline tryptase, outperforms existing methods for more accurate identification of true anaphylaxis cases, while minimizing false positives. Conducted at Nîmes university Hospital in France, this research examined 315 children and found food allergens as the primary triggers. The study highlights improved diagnostic performance with the new ratio, possibly leading to better patient outcomes in pediatric emergency departments. News Directory 3 helps you stay informed with the latest breakthroughs in medical research. Discover what’s next for enhancing pediatric care and improving the lives of children with allergies.
New Tryptase Ratio Improves Anaphylaxis Diagnosis in Children
A new diagnostic approach may improve the accuracy of anaphylaxis diagnosis in children. A decade-long study revealed that a specific ratio of serum acute tryptase to serum baseline tryptase outperforms the current consensus formula.This new ratio correctly identified more than two-thirds of true anaphylaxis cases while minimizing false positives.
the research, led by Moïse Michel, PhD, at Nîmes University Hospital in France, involved reviewing the medical records of 315 children admitted to the emergency department between 2011 and 2020 wiht suspected anaphylaxis. The median age of the children was 7.8 years, and 56.2% were boys. The study, which assessed the diagnostic performance of serum tryptase measurements, was published in the Journal of Allergy and Clinical immunology: Global.
The diagnosis of anaphylaxis was confirmed in 175 children who exhibited at least one extracutaneous systemic symptom along with evidence of systemic mast cell activation or allergic sensitization to a trigger allergen. The remaining 142 children formed the control group.researchers then compared the diagnostic performance of the existing consensus formula with five alternative tryptase interpretation algorithms to improve anaphylaxis diagnosis and medical research.
food allergens were responsible for 82% of the anaphylactic reactions. Legumes, seeds, and nuts triggered 36% of cases, followed by cow’s milk proteins in 28% of cases. Epinephrine,a common treatment for anaphylaxis,was administered to 96 children with suspected anaphylaxis (30.3%), including 14 children initially misdiagnosed due to cardiovascular involvement and a history of allergen exposure.
The study found that a ratio of serum acute tryptase to serum baseline tryptase above 1.74 demonstrated optimal diagnostic performance. It showed an area under the curve of 0.84,a sensitivity of 66.7%, and a specificity of 90%. This outperformed the current consensus formula, which has a sensitivity of 62.2% and a specificity of 80%. This improved diagnostic performance could lead to better patient outcomes.
“Our study underlines the need for better implementation of both sAT [serum acute tryptase] and sBT [serum baseline tryptase] measurements at adequate sampling times in pediatric EDs [emergency departments] and contributes to the ongoing debate on the optimal interpretation of pediatric dynamic tryptase,” the authors wrote.
What’s next
Further research is needed to validate these findings in larger, more diverse populations, including cases of grade 4 anaphylaxis, which were absent in this study. The implementation of this new tryptase ratio could significantly improve the accuracy and efficiency of anaphylaxis diagnosis in pediatric emergency departments.